In neuroblastoma, a ligand-independent oncogenic variant of TrkA, named TRKAIII, that lacks one of two functional extracellular immunoglobulin regions (IG-C1) and N-glycosylation domains has been identified [26]; however, reports of pathogenic mutations of the Trk family are otherwise scarce. The gene discussed is NTRK1; the disease is neuroblastoma.